Roy Blum

2.2k total citations
30 papers, 1.6k citations indexed

About

Roy Blum is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Roy Blum has authored 30 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 7 papers in Cancer Research and 6 papers in Oncology. Recurrent topics in Roy Blum's work include RNA Research and Splicing (7 papers), Genomics and Chromatin Dynamics (7 papers) and Epigenetics and DNA Methylation (6 papers). Roy Blum is often cited by papers focused on RNA Research and Splicing (7 papers), Genomics and Chromatin Dynamics (7 papers) and Epigenetics and DNA Methylation (6 papers). Roy Blum collaborates with scholars based in United States, Israel and Canada. Roy Blum's co-authors include Yoel Kloog, Brian David Dynlacht, Gideon Rechavi, Jasmine Jacob‐Hirsch, Christopher Bowman, Ninette Amariglio, Vasupradha Vethantham, Jemmie Cheng, Michael A. Rudnicki and Patrik Asp and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Genes & Development.

In The Last Decade

Roy Blum

30 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Roy Blum United States 20 1.3k 458 284 165 159 30 1.6k
Julia Billiard United States 17 1.1k 0.9× 332 0.7× 304 1.1× 194 1.2× 108 0.7× 26 1.6k
Monica Di Padova Italy 18 1.6k 1.2× 353 0.8× 196 0.7× 210 1.3× 132 0.8× 30 1.8k
Alessandra Drusco United States 16 1.2k 0.9× 401 0.9× 139 0.5× 139 0.8× 88 0.6× 18 1.6k
Koichi Nagasaki Japan 18 623 0.5× 363 0.8× 303 1.1× 123 0.7× 117 0.7× 31 1.1k
Maimon E. Hubbi United States 14 779 0.6× 696 1.5× 190 0.7× 120 0.7× 141 0.9× 21 1.4k
Sébastien Pinte France 17 1.1k 0.9× 412 0.9× 239 0.8× 80 0.5× 235 1.5× 25 1.4k
Adam Denley Australia 12 1.1k 0.9× 227 0.5× 189 0.7× 237 1.4× 111 0.7× 15 1.6k
Ziqiang Yuan United States 23 970 0.8× 221 0.5× 392 1.4× 140 0.8× 100 0.6× 44 1.5k
Dana Napier United States 20 1.2k 0.9× 433 0.9× 300 1.1× 111 0.7× 67 0.4× 24 1.6k
Shih‐Yin Tsai United States 13 1.0k 0.8× 315 0.7× 410 1.4× 74 0.4× 184 1.2× 17 1.4k

Countries citing papers authored by Roy Blum

Since Specialization
Citations

This map shows the geographic impact of Roy Blum's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roy Blum with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roy Blum more than expected).

Fields of papers citing papers by Roy Blum

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roy Blum. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roy Blum. The network helps show where Roy Blum may publish in the future.

Co-authorship network of co-authors of Roy Blum

This figure shows the co-authorship network connecting the top 25 collaborators of Roy Blum. A scholar is included among the top collaborators of Roy Blum based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Roy Blum. Roy Blum is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Oh, Hyun Jung, Roy Blum, Andrea J. Kriz, et al.. (2025). Jpx RNA controls Xist induction through spatial reorganization of the mouse X-inactivation center. Developmental Cell. 60(21). 2850–2861.e8. 1 indexed citations
2.
Lee, Yong Woo, Uri Weissbein, Roy Blum, & Jeannie T. Lee. (2024). G-quadruplex folding in Xist RNA antagonizes PRC2 activity for stepwise regulation of X chromosome inactivation. Molecular Cell. 84(10). 1870–1885.e9. 11 indexed citations
3.
Szántó, Attila, Rodrigo Aguilar, Barry Kesner, et al.. (2021). A disproportionate impact of G9a methyltransferase deficiency on the X chromosome. Genes & Development. 35(13-14). 1035–1054. 5 indexed citations
4.
Rosenberg, Michael A., Roy Blum, Barry Kesner, et al.. (2021). Motif-driven interactions between RNA and PRC2 are rheostats that regulate transcription elongation. Nature Structural & Molecular Biology. 28(1). 103–117. 29 indexed citations
5.
Jégu, Teddy, Roy Blum, Jesse C. Cochrane, et al.. (2019). Xist RNA antagonizes the SWI/SNF chromatin remodeler BRG1 on the inactive X chromosome. Nature Structural & Molecular Biology. 26(2). 96–109. 46 indexed citations
6.
Rosenberg, Michael A., Roy Blum, Barry Kesner, et al.. (2017). Denaturing CLIP, dCLIP, Pipeline Identifies Discrete RNA Footprints on Chromatin-Associated Proteins and Reveals that CBX7 Targets 3′ UTRs to Regulate mRNA Expression. Cell Systems. 5(4). 368–385.e15. 20 indexed citations
7.
Blum, Roy. (2015). Stepping inside the realm of epigenetic modifiers. BioMolecular Concepts. 6(2). 119–136. 10 indexed citations
8.
Blum, Roy & Yoel Kloog. (2014). Metabolism addiction in pancreatic cancer. Cell Death and Disease. 5(2). e1065–e1065. 113 indexed citations
9.
Jones, Courtney L., Teena Bhatla, Roy Blum, et al.. (2014). Loss of TBL1XR1 Disrupts Glucocorticoid Receptor Recruitment to Chromatin and Results in Glucocorticoid Resistance in a B-Lymphoblastic Leukemia Model. Journal of Biological Chemistry. 289(30). 20502–20515. 38 indexed citations
10.
Blum, Roy & Brian David Dynlacht. (2013). The role of MyoD1 and histone modifications in the activation of muscle enhancers. Epigenetics. 8(8). 778–784. 49 indexed citations
11.
Monu, Ngozi, Jeremy C. Burns, Roy Blum, et al.. (2012). Protocadherin-18 Is a Novel Differentiation Marker and an Inhibitory Signaling Receptor for CD8+ Effector Memory T Cells. PLoS ONE. 7(5). e36101–e36101. 15 indexed citations
12.
Blum, Roy, Vasupradha Vethantham, Christopher Bowman, Michael A. Rudnicki, & Brian David Dynlacht. (2012). Genome-wide identification of enhancers in skeletal muscle: the role of MyoD1. Genes & Development. 26(24). 2763–2779. 130 indexed citations
13.
Asp, Patrik, Roy Blum, Vasupradha Vethantham, et al.. (2011). Genome-wide remodeling of the epigenetic landscape during myogenic differentiation. Proceedings of the National Academy of Sciences. 108(22). E149–58. 232 indexed citations
14.
Blum, Roy, Patricia E. Burger, Christopher S. Ontiveros, et al.. (2010). Molecular Signatures of the Primitive Prostate Stem Cell Niche Reveal Novel Mesenchymal-Epithelial Signaling Pathways. PLoS ONE. 5(9). e13024–e13024. 19 indexed citations
15.
Blum, Roy, Rashmi Gupta, Patricia E. Burger, et al.. (2009). Molecular Signatures of Prostate Stem Cells Reveal Novel Signaling Pathways and Provide Insights into Prostate Cancer. PLoS ONE. 4(5). e5722–e5722. 54 indexed citations
16.
Blum, Roy, Ran Elkon, Adi Zundelevich, et al.. (2007). Gene Expression Signature of Human Cancer Cell Lines Treated with the Ras Inhibitor Salirasib ( S -Farnesylthiosalicylic Acid). Cancer Research. 67(7). 3320–3328. 40 indexed citations
17.
Blum, Roy, Itay Nakdimon, Liat Goldberg, et al.. (2006). E2F1 identified by promoter and biochemical analysis as a central target of glioblastoma cell‐cycle arrest in response to ras inhibition. International Journal of Cancer. 119(3). 527–538. 21 indexed citations
18.
Erlich, Shlomit, et al.. (2006). Ras inhibition results in growth arrest and death of androgen-dependent and androgen-independent prostate cancer cells. Biochemical Pharmacology. 72(4). 427–436. 39 indexed citations
19.
Blum, Roy & Yoel Kloog. (2005). Tailoring Ras-pathway—Inhibitor combinations for cancer therapy. Drug Resistance Updates. 8(6). 369–380. 51 indexed citations
20.
Blum, Roy, et al.. (1971). Review of Selected Army Models.. Defense Technical Information Center (DTIC). 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Julia Billiard Breakdown of academic impact, for papers by Monica Di Padova Breakdown of academic impact, for papers by Alessandra Drusco Breakdown of academic impact, for papers by Koichi Nagasaki Breakdown of academic impact, for papers by Maimon E. Hubbi Breakdown of academic impact, for papers by Sébastien Pinte Breakdown of academic impact, for papers by Adam Denley Breakdown of academic impact, for papers by Ziqiang Yuan Breakdown of academic impact, for papers by Dana Napier Breakdown of academic impact, for papers by Shih‐Yin Tsai
Rankless by CCL
2026